Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2019 ,inter alia, to consider and approve We hereby inform you that, pursuant to Regulation 29 of the Securities and Exchange Board of lndia (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, January 31, 2019 to inter alia consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter and the nine months ended December 31, 2018.
In accordance with the Companys Code of Conduct to regulate, monitor and report trading by insiders, adopted by the Board pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company is closed for the designated persons from January 16, 2019 to February 5, 2019 (both days inclusive).
वैल्यू रिसर्च से पूछें 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
